FIELD: medicine, dermatology, chemical-pharmaceutical industry. SUBSTANCE: agent comprises fluocinolone acetonide, nipagine, propylene glycol, solid paraffin, vaseline, vaseline oil, emulsifier = 1 or emulsifying cetostearyl alcohol, Trilon B and purified water and components are taken in the definite ratio. Invention provides possibility to enhance the level of specific activity of fluocinolone acetonide due to increase of its concentration without or at significant reduction of toxic properties of this substance. EFFECT: enhanced effectiveness of agent and treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-INFLAMMATORY AND ANTIBACTERIAL DRUG FOR TOPICAL USE | 1998 |
|
RU2157214C2 |
| ANTIVIRAL AGENT "GERPEVIR" FOR TOPICAL USE | 1998 |
|
RU2138265C1 |
| DERMATOLOGICAL REMEDY "MIKONAZOL" | 1998 |
|
RU2157187C2 |
| ANTI-INFLAMMATORY AND ANTIBACTERIAL DRUG FOR LOCAL USE | 1998 |
|
RU2137469C1 |
| PHARMACEUTICAL COMPOSITION ELICITING ANTI-INFLAMMATORY AND ANTI-ALLERGIC EFFECT | 2002 |
|
RU2225208C1 |
| COMBINED PREPARATION FOR TREATING SKIN DISEASES | 2002 |
|
RU2223097C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISEASES AND METHOD FOR PREPARING IT | 2011 |
|
RU2489144C2 |
| METHOD FOR TREATING IMMUNE DISEASES OF SKIN | 2006 |
|
RU2322990C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTI-ALLERGIC AND ANTI-INFLAMMATORY EFFECT | 2004 |
|
RU2281102C2 |
| AGENT "FORIDONE-GEL" FOR TREATMENT AND PROPHYLAXIS OF CARDIOVASCULAR DISEASES | 2004 |
|
RU2280438C2 |
